Mohr H - Search Results

1

The development of neutralizing antibodies in a patient receiving subcutaneous recombinant and natural interleukin-2.

Kirchner H, Körfer A, Evers P, Szamel MM, Knüver-Hopf J, Mohr H, Franks CR, Pohl U, Resch K, Hadam M, et al. Kirchner H, et al. Among authors: mohr h. Cancer. 1991 Apr 1;67(7):1862-4. doi: 10.1002/1097-0142(19910401)67:7<1862::aid-cncr2820670708>3.0.co;2-r. Cancer. 1991. PMID: 2004299

2

Low-dose subcutaneous recombinant interleukin-2 in advanced human malignancy: a phase II outpatient study.

Atzpodien J, Körfer A, Evers P, Franks CR, Knüver-Hopf J, Lopez-Hänninen E, Fischer M, Mohr H, Dallmann I, Hadam M, et al. Atzpodien J, et al. Among authors: mohr h. Mol Biother. 1990 Mar;2(1):18-26. Mol Biother. 1990. PMID: 2334534

3

Treatment with natural human interferon alpha of a CML-patient with antibodies to recombinant interferon alpha-2b.

Freund M, von Wussow P, Knüver-Hopf J, Mohr H, Pohl U, Exeriede G, Link H, Wilke HJ, Poliwoda H. Freund M, et al. Among authors: mohr h. Blut. 1988 Nov;57(5):311-5. doi: 10.1007/BF00320360. Blut. 1988. PMID: 3196882

4

Modulation of natural and interleukin-2-induced tumour-cytolytic activities by the members of a protein family related to beta-thromboglobulin.

Klein-Struckmeier A, Knüver-Hopf J, Mohr H. Klein-Struckmeier A, et al. Among authors: mohr h. Cancer Immunol Immunother. 1991;34(3):175-80. doi: 10.1007/BF01742309. Cancer Immunol Immunother. 1991. PMID: 1836749 Free PMC article.

5

Differences between natural and recombinant interleukin-2 revealed by gel electrophoresis and capillary electrophoresis.

Knüver-Hopf J, Mohr H. Knüver-Hopf J, et al. Among authors: mohr h. J Chromatogr A. 1995 Nov 24;717(1-2):71-4. doi: 10.1016/0021-9673(95)00557-7. J Chromatogr A. 1995. PMID: 8520686

6

[A gold immunoblot assay for the determination of antibodies against HIV].

Knüver-Hopf J, Mohr H. Knüver-Hopf J, et al. Among authors: mohr h. Beitr Infusionther Klin Ernahr. 1987;18:37-8. Beitr Infusionther Klin Ernahr. 1987. PMID: 3439995 German. No abstract available.

7

[Use of 2D IEF/SDS-PAGE and immunoblotting for the analysis of a factor VIII concentrate].

Knüver-Hopf J, Mohr H. Knüver-Hopf J, et al. Among authors: mohr h. Beitr Infusionther Klin Ernahr. 1987;18:186-8. Beitr Infusionther Klin Ernahr. 1987. PMID: 3125826 German. No abstract available.

8

Target structures for HIV-1 inactivation by methylene blue and light.

Bachmann B, Knüver-Hopf J, Lambrecht B, Mohr H. Bachmann B, et al. Among authors: mohr h. J Med Virol. 1995 Oct;47(2):172-8. doi: 10.1002/jmv.1890470211. J Med Virol. 1995. PMID: 8830122

9

No evidence for neoantigens in human plasma after photochemical virus inactivation.

Mohr H, Knüver-Hopf J, Lambrecht B, Scheidecker H, Schmitt H. Mohr H, et al. Ann Hematol. 1992 Nov;65(5):224-8. doi: 10.1007/BF01703949. Ann Hematol. 1992. PMID: 1457580

10

[Virus inactivation of plasma].

Schmitt H, Mohr H, Lambrecht B, Knüver-Hopf J. Schmitt H, et al. Among authors: mohr h. Beitr Infusionsther. 1991;28:82-91. Beitr Infusionsther. 1991. PMID: 1725665 German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

400 results

Search Page

Filters